Arrowstreet Capital Limited Partnership Purchases 73,396 Shares of Teleflex Incorporated $TFX

Arrowstreet Capital Limited Partnership increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 33.1% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 295,137 shares of the medical technology company’s stock after purchasing an additional 73,396 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Teleflex were worth $34,932,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in TFX. Thurston Springer Miller Herd & Titak Inc. grew its holdings in Teleflex by 242.9% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock worth $26,000 after acquiring an additional 153 shares in the last quarter. Brooklyn Investment Group lifted its position in shares of Teleflex by 258.6% in the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 150 shares during the period. True Wealth Design LLC lifted its position in shares of Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock worth $37,000 after purchasing an additional 310 shares during the period. Parallel Advisors LLC boosted its stake in shares of Teleflex by 43.1% during the second quarter. Parallel Advisors LLC now owns 455 shares of the medical technology company’s stock valued at $54,000 after purchasing an additional 137 shares in the last quarter. Finally, Covestor Ltd increased its holdings in Teleflex by 64.9% during the first quarter. Covestor Ltd now owns 480 shares of the medical technology company’s stock valued at $66,000 after buying an additional 189 shares during the period. 95.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on TFX. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Royal Bank Of Canada reduced their price target on Teleflex from $135.00 to $120.00 and set a “sector perform” rating for the company in a research report on Friday, November 7th. Truist Financial dropped their price objective on Teleflex from $128.00 to $120.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research note on Monday. Finally, Wells Fargo & Company reduced their target price on shares of Teleflex from $131.00 to $114.00 and set an “equal weight” rating for the company in a report on Friday, November 7th. One investment analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $134.57.

Teleflex Price Performance

Shares of TFX stock opened at $120.54 on Friday. Teleflex Incorporated has a fifty-two week low of $102.58 and a fifty-two week high of $188.87. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The firm has a market capitalization of $5.33 billion, a price-to-earnings ratio of -16.40, a PEG ratio of 1.42 and a beta of 0.95. The stock’s 50-day simple moving average is $119.98 and its 200-day simple moving average is $120.77.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to analyst estimates of $892.79 million. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. Teleflex’s revenue was up 19.4% on a year-over-year basis. During the same period last year, the firm posted $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Friday, November 14th will be issued a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex’s payout ratio is -18.50%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.